Geneva – The International Air Transport Association
(IATA) welcomed Singapore’s acceptance of pre-departure COVID-19 PCR test
results on the IATA Travel Pass.
From 1 May 2021, passengers traveling to Singapore will be able to use IATA
Travel Pass to share their pre-departure COVID-19 PCR test results upon
check-in with their airline, as well as on-arrival at the immigration
checkpoints at Changi Airport. This is part of an ongoing collaboration
between the Civil Aviation Authority of Singapore (CAAS) and IATA to
facilitate seamless and efficient travel through digital certificates of
COVID-19 tests.
“Having the confidence of an aviation leader like Singapore accept IATA
Travel Pass is hugely significant. Ongoing trials put us on track for IATA
Travel Pass to be a critical tool for the industry’s restart by delivering
verified travel health credentials to governments. And travelers can have
complete confidence that their personal data is secure and under their own
control. The success of our joint efforts will make IATA’s partnership with
the government of Singapore a model for others to follow,” said Willie Walsh,
IATA’s Director General.
“We have built upon our long standing and deep partnership with IATA to
develop solutions to facilitate travel. This latest collaboration with IATA
demonstrates our shared commitment to drive the adoption of digital health
certificates and restore international air travel. As we look to safely
rebuild the Changi air hub, we will continue to explore other solutions that
can provide similarly secure and verifiable means of sharing health
certificates for safe international travel,” said Kevin Shum, CAAS
Director-General.
Digital health certificates will be a key feature in air travel moving
forward. Establishing trusted, secure solutions to verify the health
credentials of travellers will be critical in facilitating smooth air travel
and safeguarding public health. The IATA Travel Pass is a personal secure
digital wallet solution that can be used by passengers to obtain and store
their COVID-19 test results from accredited laboratories.
Following the successful trials by Singapore Airlines, the Singapore health
and border control authorities will accept the IATA Travel Pass as a valid
form of presentation of COVID-19 pre-departure test results for entry into
Singapore. The information presented on the IATA Travel Pass will be in a
format that satisfies Singapore’s prevailing COVID-19 pre-departure test
requirements for entry into Singapore.
More than 20 airlines have announced trials of the IATA Travel Pass.
Travelers to Singapore intending to use the IATA Travel Pass should check
with the airline they are travelling with for eligibility to use the IATA
Travel Pass.
For more information, please contact:
Corporate Communications
Tel: +41 22 770 2967
Email: corpcomms@iata.org
Notes for Editors:
IATA (International Air Transport Association) represents
some 290 airlines comprising 82% of global air traffic.
You can follow us at twitter.com/iata for
announcements, policy positions, and other useful industry information.
COVID-19
media kit.
Travel
Pass news and media kit.
|